Skip to content

Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma

Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00842647
Acronym
HCC
Enrollment
1200
Registered
2009-02-12
Start date
2006-07-31
Completion date
2009-08-31
Last updated
2009-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Keywords

Sensitivity, specificity, positive rate, negative rate

Brief summary

This study prospectively evaluates the accuracy of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Interventions

None listed

Sponsors

Ministry of Health, China
CollaboratorOTHER_GOV
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. All the patients who receive hepatomy in our department 2. Diagnose as HCC 3. Diagnosis of HCC is confirmed by noninvasive criteria for HCC as used by the American Association for the Study of the Liver guidelines 4. No history of previous treatments 5. No pathological diagnosis before treatment

Countries

China

Contacts

Primary ContactMin-Shan Chen, MD
Chminsh@mail.sysu.edu.cn86-2087343117

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026